|
Symbol |
Name |
Market Cap |
Exchange |
Z-Score |
 | ABT  | Abbott Laboratories | $76.1B | NYSE | 2.784 |
 | ACST  | Acasti Pharma Inc | $13.5M | NASDAQ | |
 | ACET  | Aceto Corporation | $424.6M | NASDAQ | 3.5928 |
 | ADMP  | Adamis Pharmaceuticals Corp | $78.3M | NASDAQ | 1.4017 |
 | AEGR  | Aegerion Pharmaceuticals, Inc. | $56.6M | NASDAQ | -0.3099 |
 | AKRX  | Akorn, Inc. | $4.2B | NASDAQ | 2.6767 |
 | AMAG  | AMAG Pharmaceuticals, Inc. | $667.9M | NASDAQ | 0.73 |
 | FOLD  | Amicus Therapeutics, Inc. | $1.0B | NASDAQ | 0.1917 |
 | AMPH  | Amphastar Pharmaceuticals Inc | $743.8M | NASDAQ | 5.0177 |
 | APRI  | Apricus Biosciences Inc | $14.0M | NASDAQ | -94.1076 |
 | AQXP  | Aquinox Pharmaceuticals Inc | $251.4M | NASDAQ | 17.1159 |
 | ARLZ  | Aralez Pharmaceuticals Inc | $102.7M | NASDAQ | |
 | AZN  | AstraZeneca plc (ADR) | $42.8B | NYSE | 0.9968 |
 | BDSI  | BioDelivery Sciences International, Inc. | $101.8M | NASDAQ | -6.6739 |
 | BLFS  | BioLife Solutions Inc | $29.1M | NASDAQ | -7.7016 |
 | BMY  | Bristol-Myers Squibb Co | $90.8B | NYSE | 5.3617 |
 | CBM  | Cambrex Corporation | $1.7B | NYSE | 6.8941 |
 | CTLT  | Catalent Inc | $4.0B | NYSE | 1.0391 |
 | CLRB  | Cellectar Biosciences Inc | $17.2M | NASDAQ | 1.9188 |
 | CPHR  | Cipher Pharmaceuticals Inc | $77.8M | NASDAQ | |
 | COLL  | Collegium Pharmaceutical Inc | $221.7M | NASDAQ | 4.9566 |
 | CLCD  | CoLucid Pharmaceuticals Inc | $895.6M | NASDAQ | 11.1653 |
 | CXRX  | Concordia International Corp | $76.1M | NASDAQ | |
 | CORT  | Corcept Therapeutics Incorporated | $1.2B | NASDAQ | 21.6297 |
 | CORI  | Corium International Inc | $165.1M | NASDAQ | -1.2208 |
 | RDY  | Dr.Reddy's Laboratories Ltd (ADR) | $6.9B | NYSE | 5.615 |
 | LLY  | Eli Lilly and Co | $88.2B | NYSE | 3.4531 |
 | EVOK  | Evoke Pharma Inc | $39.5M | NASDAQ | -2.8642 |
 | EYEG  | Eyegate Pharmaceuticals Inc | $18.5M | NASDAQ | -9.8494 |
 | GALE  | Galena Biopharma Inc | $21.2M | NASDAQ | -5.9726 |
 | GSK  | GlaxoSmithKline plc (ADR) | $107.1B | NYSE | 1.1744 |
 | HSGX  | Histogenics Corp | $22.3M | NASDAQ | -5.564 |
 | HZNP  | Horizon Pharma PLC | $1.7B | NASDAQ | 0.5876 |
 | IBIO  | Ibio Inc | $33.9M | NYSE MKT | -0.541 |
 | IMNP  | Immune Pharmaceuticals Inc | $23.1M | NASDAQ | -1.9 |
 | IPXL  | Impax Laboratories Inc | $1.3B | NASDAQ | 1.0223 |
 | INNL  | Innocoll Holdings PLC | $64.1M | NASDAQ | -6.2319 |
 | INVA  | Innoviva Inc | $1.3B | NASDAQ | 2.0301 |
 | IPCI  | IntelliPharmaCeutics Intl Inc (USA) | $52.6M | NASDAQ | -5.1953 |
 | JNJ  | Johnson & Johnson | $336.3B | NYSE | 4.7832 |
 | JNP  | Juniper Pharmaceuticals Inc | $47.7M | NASDAQ | -2.5562 |
 | LCI  | Lannett Company, Inc. | $841.7M | NYSE | 1.3262 |
 | MRNS  | Marinus Pharmaceuticals Inc | $26.0M | NASDAQ | -2.6544 |
 | MRK  | Merck & Co., Inc. | $174.8B | NYSE | 3.2239 |
 | MBRX  | Moleculin Biotech Inc | $13.9M | NASDAQ | 6.1949 |
 | MYL  | Mylan NV | $19.8B | NASDAQ | 2.0086 |
 | NAII  | Natural Alternatives International, Inc. | $67.0M | NASDAQ | 5.2017 |
 | NEOS  | Neos Therapeutics Inc | $121.3M | NASDAQ | -2.006 |
 | NEOT  | Neothetics Inc | $29.7M | NASDAQ | 2.0834 |
 | CUR  | Neuralstem, Inc. | $47.7M | NASDAQ | -8.0067 |
 | NVS  | Novartis AG (ADR) | $190.7B | NYSE | 2.2191 |
 | NVO  | Novo Nordisk A/S (ADR) | $80.0B | NYSE | 7.2506 |
 | OPK  | Opko Health Inc. | $4.0B | NASDAQ | 3.8091 |
 | PCRX  | Pacira Pharmaceuticals Inc | $1.9B | NASDAQ | 6.6106 |
| PTHN  | Patheon NV | $3.7B | NYSE | 1.2425 |
 | PTX  | Pernix Therapeutics Holdings Inc | $55.6M | NASDAQ | -1.1198 |
 | PFE  | Pfizer Inc. | $197.1B | NYSE | 2.0668 |
 | SGNT  | Sagent Pharmaceuticals Inc | $346.4M | NASDAQ | 2.9783 |
 | SNY  | Sanofi SA (ADR) | $62.5B | NYSE | 1.119 |
 | SCLN  | SciClone Pharmaceuticals, Inc. | $484.4M | NASDAQ | 11.773 |
 | SCYX  | SCYNEXIS Inc | $43.6M | NASDAQ | -1.4089 |
 | SHPG  | Shire PLC (ADR) | $54.8B | NASDAQ | 1.1194 |
 | SPHS  | Sophiris Bio Inc | $77.2M | NASDAQ | |
 | TARO  | Taro Pharmaceutical Industries Ltd. | $4.9B | NYSE | 16.0755 |
 | TLGT  | Teligent Inc | $471.0M | NASDAQ | 2.4269 |
 | TTPH  | Tetraphase Pharmaceuticals Inc | $291.0M | NASDAQ | 14.2576 |
 | TEVA  | Teva Pharmaceutical Industries Ltd (ADR) | $32.2B | NYSE | 0.5715 |
 | TBPH  | Theravance Biopharma Inc | $1.8B | NASDAQ | 3.0191 |
 | UG  | United-Guardian, Inc. | $64.7M | NASDAQ | 33.9864 |
 | VRX  | Valeant Pharmaceuticals Intl Inc | $4.6B | NYSE | 0.1617 |